Исследование на клеточных культурах молекулярных механизмов антипролиферативного и цитотоксического действия витамина К3
Диссертация
Таким образом, данная работа, направленная на дальнейшее понимание молекулярных механизмов противоопухолевого действия витамина КЗ как химиотерапевтического препарата, представляет не только научный, но в перспективе и практический интерес, связанный с дальнейшим использованием витамина КЗ в медицинской практике. Впервые исследованная в данной работе комбинация витамина КЗ и азидотимидина имела… Читать ещё >
Список литературы
- Kerr J.F.R., Wyllie А.Н., Currie A.R. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. // Br. J. Cancer, I972, v. 26, pp. 239−257.
- Steller H. Mechanisms and genes of cellular suicide. // Science, 1995, v. 267, pp. 1445−1449.
- Rudin C.M., Thompson C.B. Apoptosis and disease: regulation and clinical relevance of programmed cell death. // Annu. Rev. Med., 1997, v. 48, pp. 267 281.
- Vaux D.L., Strasser A. The molecular biology of apoptosis. // Proc. Natl. Acad. Sci. USA, 1996, v. 93, pp. 2239−2244.
- Salvesen G.S., Ditix V.M. Caspases: intracellular signaling by proteolysis. // Cell, 1997, v. 91, pp. 443−446.
- Hetts S.W. To die or not to die. // JAMA, 1998, v. 279, pp. 300−307.
- Vaishnaw A.K., McNally J.D., Elkon K.B. Apoptosis in the rheumatic diseases. //Arthritis and Rheumatism, 1997, v.40, pp. 1917−1927.
- Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. // Cell, 1994, v.76, pp. 777−779.
- O.Ellis R.E., Yuan H., Horvitz H.R. Mechanisms and functions of cell death. // Ann. Rev. Cell Dev. Biol., 1991, v.7, pp. 663−698.
- Yuang J.Y., Horvitz R.H. Genetic mosaic analysis of ced-3 and ced-4, two genes that control programmed cell death in the nematode C elegans. // Dev. Biol., 1990, v.138, pp.33−41.
- Hengartner M.O., Ellis R.E., Horvitz R.H. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. // Nature, 1992, v.356, pp. 494 499.
- Enari M., Hase A., Nagata S. Apoptosis by a cytosolic extract from Fas-activated cells. // EMBO J., 1995, v. 14, 5201−5208.
- Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. // Nature, 1996, v.380, pp.723−726.
- Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C elegans ced-4, participates in cytochrome c-dependent activation of caspase-3. // Cell, 1997, v. 90, pp. 405−413.
- Hengartner M.O., Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. // Cell, 1994, v. 76, pp. 665−676.
- Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. // Cell, 1993, v. 75, pp. 241−251.
- Yang E., Korsmeyer S.J. Molecular thanatopsis: a discourse on the Bcl2 family and cell death. // Blood, 1996, v. 88, pp. 386−401.
- Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negeshi I., Senju S., Zhang Q., Fujii S., Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. // Science, 1995, v. 267, pp. 1506−1510.
- Veis D.J., Sorenson C.M., Shutter J.R., Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. // Cell, 1993, v. 75, pp. 229−240.
- Knudson C.M., Tung K.S., Tourtellotte W.G., Brown G.A., Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. // Science, 1995, v. 270, pp. 96−99.
- Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gomez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. // J. Exp. Med., 1996, v. 183, pp. 1533−1544.
- Krippner A., Matsuno-Yagi A., Gottlieb R., Babior B. Loss of function of cytochrome c in Jurkat cells undergoin Fas-mediated apoptosis. // J. Biol. Chem., 1996, v. 271, pp. 21 629−21 636.
- Ray C.A., Black R.A., Kronheim S.R. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-l? converting enzyme. // Cell, 1992, v. 69, pp. 597−604.
- Clem R.J., Hardwick J.M., Miller L.K. Anti-apoptotic genes of baculoviruses. // Cell Death Differentiation, 1996, v. 3, pp. 9−16.
- Nagata S. Apoptosis by death factor. // Cell, 1997, v. 88, pp. 355−365.
- Nagata S., Golstein P. The Fas death factor. // Science, 1995, v. 267, pp. 1449−1456.
- Reap E., Roof K., Maynor K., Borrero M., Booker J., Cohen P. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interaction. // Proc. Natl. Acad. Sci. USA, 1997, v. 94, pp. 5750−5755.
- Rehemtulla A., Hamilton C.A., Chinnaiyan A.M., Dixit V. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/Apo-1). // J. Biol. Chem., 1997, v. 272, pp. 25 783−25 786.
- Friesen C., Herr I., Krammer P.H., Debatin K.M. Involvement of the CD95 (Apo-l/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. //Nat. Med., 1996, v. 2, pp. 574−577.
- Hueber A.O., Zornig M., Lyon D., Suda T., Nagata S., Evan G. Requirement for the CD95 receptor-ligand pathway in c-myc-induced apoptosis. // Science, 1997, v. 278, pp. 1305−1309.
- Cohen P.L., Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. // Annu. Rev. Immunol., 1991, v. 9, pp. 243−269.
- Tanaka M., Suda T., Haze K., Nakamura N., Sato K., Kimura F. Fas ligand in human serum. // Nat. Med., 1996, v.2, pp. 317−322.
- Trauth B.C., Klas C., Peters A.MJ., Matzuku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. // Science, 1989, v. 245, pp. 301−305.
- Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/Apol contains a sequence motif related to the death domain. // J. Biol. Chem., 1995, v. 270, pp. 7795−7798.
- Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involement of MACH, a novel MORTl/FADD-interacting protease, in Fas/Apol- and TNF receptor-induced cell death. // Cell, 1996, v. 85, pp. 803−815.
- Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. // Cell, 1991, v. 66, pp. 233 243.
- Adachi M., Suematsu S., Kondo T., Ogasawara J., Tanaka T., Yoshida N., Nagata S. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. //Nat. Gen., 1995, v. 11, pp. 294−300.
- Rieux-laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fisher A., Villarty J.P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. // Science, 1995, v. 268, pp. 1347−1349.
- Darmon A.J., Nicholson D.W., Bleackley R.C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. // Nature, 1995, v. 377, pp. 446−448.
- Bellgrau D., Gold D., Selawary H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. // Nature, 1995, v. 377, pp. 630−632.
- Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. // Science, 1995, v. 270, pp. 1189−1192.
- Kasahara B.Y., Iwai K., Yachie A., Ohta K., Konno A., Seki H., Miyawaki T., Taniguchi N. Involvement of reactive oxygen intermediates in spontaneous and CD95(Fas/APO-l)-mediated apoptosis of neutrophils. // Blood, 1997, v. 89, pp. 1748−1753.
- Um H.D., Orenstein J.M., Wahl S.M. Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. // J. Immunol., 1996, v. 156, pp. 3469−3477.
- Kohno T., Yamada Y., Hata T., Mori H., Yamamura M., Tomonaga M., Urata Y., Goto S., Kondo T. Relation of oxidative stress and glutathione synthesis to
- CD95(Fas/APO-l)-mediated apoptosis of adult T cell leukemia cells. // J. Immunol., 1996, v. 156, pp. 4722−4728.
- Chiba T., Takahashi S., Sato N., Ishii S., Kikuchi K. Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. // Eur. J. Immunol., 1996, v. 26, pp. 1164−1169.
- Dobbelsteen D.J., Nobel C.S., Schlegel J., Cotgreave I.A., Orrenius S., Slater A.F. Rapid and spesific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. // J. Biol. Chem., 1996, v. 271, pp. 15 420−15 427.
- Landowski T.H., Gleason-Guzman M.C., Dalton W.S. Selection for drug resistance results in resistance to Fas-mediated apoptosis. // Blood, 1997, v. 89, pp. 1854−1861.
- McGahon A.J., Pereira A.P., Daly L., Cotter T.G. Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. // Br. J. Haematol., 1998, v. 101, pp. 539 547.
- Dam H. The antihemorrhagic effects of vitamin K in the chick. // Biochem. J., 1935, v. 29, pp. 1273−1275.
- Chlebowski R.T., Akman S.A., Block J.B. Vitamin К in the treatment of cancer. // Cancer Treat. Reviews, 1985, v. 12, pp. 49−63.
- Машковский M.Д. Лекарственные средства. // Москва, «Медицина», 1993, 4.2, стр. 38.
- Dendy P.P. Further studies on the uptake of Synkavite and a radioactive analog into tumor cells in tissue culture. // Br. J. Cancer, 1970, v. 24, pp. 817 825.
- Buchal S.D., Bell R.G. Vitamin К dependent carboxylation in spleen and kidney. // Vitamin К Metabolism and Vitamin К Dependent Protein. University Park Press, Baltimore, 1980, pp. 299−302.
- Young R.C., Ozols R.F., Myers C.E. The anthracycline antibiotic drug. // N. Engl. J. Med., 1981, v. 305, pp. 139−153.
- Mitchell J.S. Investigation of tritiated menadiol sodium diphosphate (T-MNDP) as a radioactive drug. // Br. J. Cancer, 1974, v. 229, pp. 373−388.
- Rao K., McBride, Oleson J.J. Recognition and evaluation of lapachol as an antitumor agent. // Cancer Res., 1968, v. 28, pp. 1952−1954.
- Block J.B., Serpick A.A., Miller W., Weirnik P.W. Early clinical studies with lapachol (NSC:11 905). // Cancer Chemother. Rep., 1974, v. 4, pp. 27−28.
- Kummer D., Kraml F. Studies on thymidine-triphosphate synthesis in malignant tumors. // Radiology Krebsforch. Klin. Onkol., 1971, v. 99, pp. 409 415.
- Chang J., Hall T. In vitro effects of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemia cells and Walker tumor cells. // Oncology, 1973, v. 28, pp. 232−237.
- Ryan J.J., Ketcham A.S., Wexler H. Reduced incindence of spontaneous metastases with long-term coumarin therapy. // Ann. Surg., 1968, v. 168, pp. 163−168.
- Ryan J.J., Ketcham A.S., Wexler H. Warfarin treatment of mice bearing tumors: Effect on spontaneous metastases. // Science, 1968, v. 62, pp. 14 931 494.
- Zacharski L., Henderson W.G., Rickles F.R., Forman W., Cornell C., Forcier R., Edwards R., Heardley E. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prastate. // Cancer, 1984, v. 53, pp. 2046−2052.
- Zacharski L., Henderson W.G., Rickles F.R., Forman W., Cornell C., Forcier R., Harrower H.W., Johnson R.D. Effect of warfarin on survival in small cell carcinoma of the lung. // J. Am. Med. Assoc., 1981, v. 245, pp. 831−835.
- Chlebowski R.T., Dietrich M., Akman S.A., Block J.B. Vitamin K3 inhibition of human tumor growth in the soft agar assay system. // Proc. Am. Soc. Clin. Oncol., 1984, v. 3, pp. 93.
- Akman S.A., Takamura K., Chlebowski R.T., Kusu F., Block J.B. Analysis of menadione (vitamin K3) in plasma by differential pulse polarography. // Proc. Am. Soc. Clin. Oncol., 1984, v. 3, pp. 37.
- Chlebowski R.T., Block J.B., Dietrich M. Use of quinones, vitamin K and warfarin to enhance antimetabolite effects in caner: laboratory and clinical observations. // Curr. Chemother. Immunother., 1981, v. 2, pp. 1532−1533.
- Nishikawa Y., Carr B.I., Wang M., Kar S., Finn F., Dowd P., Zheng Z.B., Kerns J., Naganathan S. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. // J. Biol. Chem., 1995, v. 270, pp. 28 304−28 307.
- Wu F.Y., Chang N.T., Chen W.J., Juan C.C. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fosand c-myc in nasopharyngeal carcinoma cells. // Oncogene, 1993, v. 8, pp. 2237−2241.
- Yaguchi M., Miyazawa K., Katagiri T., Nishimaki J., Kizaki M., Tohyama K., Toyama K. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enchance the effect of all-trans retinoic acid. // Leukemia, 1997, v. 11, pp. 779−783.
- Juan C.C., Wu F.Y. Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase. // Biochem. Biophys. Res. Commun., 1993, v. 190, pp. 907−913.
- Rossi F., Zoppi G. Effect of menadione on the phagocytic activity of guinea pig polymorphonuclear leukocytes. // Experientia, 1966, v. 22, pp. 433−434.
- Bellomo G., Jewell S.A., Orrenius S. The metabolism of menadione impairs the ability of rat liver mitochondria to take up and retain calcium. // J. Biol. Chem., 1982, v. 257, pp. 11 558−11 562.
- Gallin J.I., Seligmann B.E., Cramer E.B., Schiffinan E., Fletcher M.P. Effects of vitamin K on human neutrophil function. // J. Immunol., 1982, v. 128, pp. 1399−1408.
- Jewell S.A., Bellomo G., Thor H., Orrenius S., Smith M.T. Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. // Science, 1982, v. 217, pp. 1257−1258.
- McConkey D.J., Hartzell P., Nicotera P., Wyllie A.H., Orrenius S. Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress. // Toxicol Lett., 1988, v. 42, pp. 123−130.
- Schulze-Osthoff K., Walczak H., Droge W., Krammer P.H. Cell nucleus and DNA fragmentation are not required for apoptosis. // J. Cell Biol., 1994, v. 127, pp. 15−20.
- Gabai V.L., Seilanov A.S., Makarova Y.M., Mosin A.F. Oxidative stress, disturbance of energy balance, and death of ascites tumour cells under menadione (vitamin K3) action. // Biomed. Sci., 1990, v. 1, pp. 407−413.
- Malorni W., Iosi F., Mirabelli F., Bellomo G. Cytoskeletion as a target in menadione-induced oxidative stress in cultured mammalian cells: alterations underlying surface bleb formation. // Chem. Biol. Interact., 1991, v. 80, pp. 217−236.
- Malorni W., Iosi F., Santini M.T., Testa U. Menadione-induced oxidative stress leads to a rapid down-modulation of transferrin receptor recycling. // J. Cell Sci., 1993, v. 106, pp. 309−318.
- Malorni W., Masella R., Santini M.T., Iosi F., Samoggia P., Cantafora A., Merrell D., Peterson S.W. Human erythrocyte insulin receptor processing is affected by the oxidizing agent menadione. // Exp. Cell Res., 1993, v. 206, pp. 195−203.
- Ross D., Thor H., Threadgill M.D., Sandy M.S., Smith M.T., Moldeus P., Orrenius S. The role of oxidative processes in the cytotoxicity of substituted 1,4-naphtoquinones in isolated hepatocytes. // Archives Biochem. Biophys., 1986, v. 248, pp. 460−466.
- Ngo E.O., Sun T.P., Chang J.Y., Wang C.C., Chi K.H., Cheng A.L., Nutter L.M. Menadion-induced DNA damage in a human tumor cell line. // Biochem. Pharmacol., 1991, v. 42, pp. 1961−1968.
- Collins A.R., Dobson V.L., Dusinska M., Kennedy G., Stetina R. The comet assay: what can it really tell us? // Mutation Res., 1997, v. 375, pp. 183−193.
- Gratzner H.G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. // Science, 1982, v. 218, pp. 474−475.
- Roberts R.A., Nebert D.W., Hickman J.A., Richburg J.H., Goldsworthy T.L. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. // Fundamental Applied Toxicology, 1997, v. 38, pp. 107−115.
- Su Y.Z., Duarte T.E., Weisenthal L.M. Selective enchancement by menadiol of in vitro drug activity in human lymphatic neoplasms. // Cancer Treat. Rep., 1987, v. 71, pp. 619−625.
- Parekh H., Chavan S., Chitnis M. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells. // Anticancer Drugs, 1991, v. 2, pp. 159−168.
- Venugopal M., Jamison J.M., Gilloteaux J., Koch J.A., Summer M., Giammar D., Sowick C., Summers J.L. Synergistic antitumor activity of vitamin C and K3 on human urologic tumor cell lines. // Life Sciences, 1996, v. 59, pp. 1389−1400.
- Zhen Y.S., Taniki T., Weber G. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methtrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. // Oncol. Res., 1992, v. 4, pp. 73−78.